healthcare.digital August 23, 2018
The Innovative Medicines Initiative (IMI) is planning a substantial health blockchain project. The breadth of reach extends from the pharma supply chain and clinical trials through to health data. The Blockchain Enabled Healthcare program aims to partner nine big pharma companies with a consortium of stakeholders. In addition to the healthcare community and patients, the consortium will include SME blockchain companies and universities.
The IMI is a public-private partnership between the EU and the European pharmaceutical industry represented by EFPIA. For the Blockchain Enabled Healthcare program, the IMI is earmarking up to 18 Million Euros which is expected to last three years.
For any blockchain ecosystem, there’s a need to involve all the...
Today's Sponsors
Today's Sponsor